Article information
Resumen
Las neumonías intersticiales idiopáticas (NII) constituyen un reto diagnóstico para neumólogos, radiólogos y patólogos, comenzando por su clasificación, objeto de controversia en la actualidad. El estudio funcional respiratorio supone un elemento básico para establecer el diagnóstico, orientar en el pronóstico, controlar la evolución y monitorizar la respuesta al tratamiento. La exploración radiológica imprescindible para el diagnóstico de las NII es la tomografía computarizada de alta resolución (TCAR), que además puede ofrecer datos de la actividad y del pronóstico de la enfermedad.
Palabras clave:
Clasificación
Estudio funcional respiratorio
Neumonías intersticiales idiopáticas
Tomografía computarizada de alta resolución
Abstract
Idiopathic interstitial pneumonias (IIPs) are a diagnostic challenge for pneumologists, radiologists and pathologists alike. The classification of IPPs is currently controversial. Pulmonary function testing is an essential component in order to establish a diagnosis and is required to guide prognosis and follow-up and monitor treatment outcome. High-resolution computed tomography is also essential for the diagnosis of IPPs and may also provide data on disease activity and prognosis.
Keywords:
Classification
Pulmonary function testing
Idiopathic interstitial pneumonia
High resolution CT
Full text is only aviable in PDF
Bibliografía
[1.]
A. Xaubet, J. Ancochea, R. Blanquer, et al.
Normativa para el diagnóstico y tratamiento de las enfermedades pulmonares intersticiales difusas.
Arch Bronconeumol, 39 (2003), pp. 580-600
[2.]
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus.
Classification of the Idiopathic Interstitial Pneumonias.
Am J Respir Crit Care Med, 165 (2002), pp. 277-304
[3.]
J. Ancochea, J. Gómez, J. Vilar, A. Xaubet.
Consenso para el diagnóstico de las neumonías intersticiales idiopáticas.
Arch Bronconeumol, 46 (2010), pp. 1-21
[4.]
G. Raghu, H.R. Collard, J.J. Egan, et al.
An Official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Am J Respir Crit Care Med, 183 (2011), pp. 788-824
[5.]
M. Demets, J. Behr, R. Buhl, et al.
IFIGENIA Study group. High-dose acetylcysteine in idiopathic pulmonary fibrosis.
N Engl J Med, 353 (2005), pp. 2229-2242
[6.]
B.W. Kinder, H.R. Collard, L. Koth, et al.
Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?.
Am J Respir Crit Care Med, 176 (2007), pp. 691-697
[7.]
T. Johkoh.
Imaging of idiopathic interstitial pneumonia.
Clin Chest Med, 29 (2009), pp. 133-147
[8.]
R. Du Bois, T.E. King.
Challenges in pulmonary fibrosis-5: The NSIP/UIP debate.
Thorax, 62 (2007), pp. 1008-1012
[9.]
R.R. Patel, J.H. Ryu, R. Vassallo.
Cigarette smoking and diffuse lung disease.
Drugs, 68 (2008), pp. 1511-1527
[10.]
J.H. Ryu, J.L. Myers, S.A. Capizzi, et al.
Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease.
Chest, 127 (2005), pp. 178-184
[11.]
D.J. Gottllieb, G.L. Snider, Lung function in pulmonary fibrosis..
Pulmonary fibrosis, pp. 85-133
[12.]
P.W. Boros, M. Franczuk, S. Wesolowski.
Value of spirometry in detecting volume restriction in interstitial lung disease patients.
Respiration, 71 (2004), pp. 374-379
[13.]
M. Mura, A. Ferreti, O. Ferro, et al.
Functional predictors of exertional dyspnea, 6-min walking distance and HRCT fibrosis score in idiopathic pulmonary fibrosis.
Respiration, 73 (2006), pp. 495-502
[14.]
V.N. Lama, K.R. Flaherty, G.B. Toews, et al.
Prognostic value of desaturation during 6-minute walk test in idiopathic interstitial pneumonia.
Am J Respir Crit Care Med, 168 (2003), pp. 1084-1090
[15.]
T. Eaton, P. Young, D. Milne, et al.
Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia.
Am J Respir Crit Care Med, 171 (2005), pp. 1150-1157
[16.]
K. Flaherty, A. Andrei, S. Murray, et al.
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.
Am J Respir Crit Care Med, 174 (2006), pp. 803-809
[17.]
C.J. Lettieri, S.D. Nathan, R.F. Browning, et al.
The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis.
Respir Med, 100 (2006), pp. 1734-1741
[18.]
D.J. Lederer, S.M. Arcasoy, J.S. Wilt, et al.
Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med, 174 (2006), pp. 659-664
[19.]
J. Ribas.
Aplicabilidad de las pruebas de esfuerzo en Neumología.
Arch Bronconeumol, 36 (2000), pp. 44-51
[20.]
ERS Task Force on Standardization of Clinical Exercise Testing.
European Respiratory Society. Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies.
Eur Respir J, 10 (1997), pp. 2662-2689
[21.]
C.D. Fell, L.X. Liu, C. Motika, et al.
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med, 179 (2009), pp. 402-407
[22.]
E.D. Manali, P. Lyberopoulos, C. Triantafillidoy, et al.
MRC chronic dyspnea scale: relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic fibrosis patients: a prospective study.
BMC Pulmonary Medicine, 10 (2010), pp. 32
[23.]
S. Harari, A. Caminati.
Update on diffuse parenchymal lung disease.
Eur Respir Rev, 19 (2010), pp. 97-108
[24.]
J.M. Sánchez Varilla, S. Recio Gallardo, García Ibarra, et al.
Aproximación de la tomografía computarizada de alta resolución a la histología de la enfermedad pulmonar intersticial difusa.
Revista Española de Patología Torácica, 21 (2009), pp. 189-192
Copyright © 2011. Sociedad Española de Neumología y Cirugía Torácica
